MBA
LAW
LANGUAGES

MOLECULAR INSIGHT PHARMACEUTICA MIPI (NASDAQ)

$ 3.60

11/18/2008 20:09

Sponsored by

Change: unch (unch%)
Volume: 27,246

Avg. Volume:	27297
P/E Ratio:	0
EPS (Annual):	-3.56
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	24,980
Institutional Shareholders:	31.79%

Last:	3.60
Change:	unch (unch%)
Prev. Close:	3.60
Open:	4.19
Day's Range:	3.26 - 4.35
52wk Range:	3.26 - 9.63
Market Value:	104,410
Beta:

12-month EPS Change:	0.00%
Total Return Last 12 Months:	-45.29%
Total Return Last 3 Years:	-159.42%
Total Return Last 5 Years:	-74.45%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on MIPI

Alert me

Molecular Insight names 4 directors to board

(CAMBRIDGE, Mass.)Biotechnology company Molecular Insight Pharmaceuticals Inc. on Monday added four new directors to its board, including employees of GlaxoSmithKline PLC and Novartis AG.READ MORE

Sep 22, 2008 11:06AM

Keywords: MIPI, GSK, NVS

Earnings roundup: ING, Axel Springer

Among the earnings stories for Wednesday, Aug. 13, from AP Financial News: AMSTERDAM, Netherlands (AP)--ING Groep NV, the Dutch insurer and bank, said Wednesday its second quarter ...READ MORE

Aug 13, 2008 1:41PM

Keywords: ING, MIPI, BVF

Molecular Insight reports larger 2Q loss

(CAMBRIDGE, Mass.)Biotechnology company Molecular Insight Pharmaceuticals Inc. reported a larger second-quarter loss Wednesday, as it spent more money to develop its drug candidates.READ MORE

Aug 13, 2008 11:38AM

Keywords: MIPI, TRIN